FindTrial
Sign In

NGS-based liquid biopsy for tumor genotyping in patients with advanced or progressive NSCLC

NGS-based liquid biopsy for tumor genotyping in patients with advanced or progressive NSCLC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16007900
Enrollment
Unknown
Registered
2016-02-05
Start date
2016-02-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

Interventions

Gold Standard:
Index test:

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: advanced or progressive NSCLC

Exclusion criteria

Exclusion criteria: tissue sample unavailable or driver gene unknown

Design outcomes

Primary

MeasureTime frame
accuracy;—

Countries

China

Contacts

Public ContactLi Weimin
weimi003@yahoo.com+86 18980601009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026